A new generation of oral tablets, multi-target agonists, and next-generation injectables is reshaping the competitive landscape at pace, with fresh regulatory approvals, pivotal Phase 3 data, and an expanding list of indications that stretches far beyond weight loss and type 2 diabetes
Notably, Mounjaros manufacturer, Eli Lilly, has taken legal action against telehealth platforms and online pharmacies selling illegal compounded versions of its brand-name products
Structure/Function Claims. Available at: United States Department of Agriculture (USDA) Agricultural Marketing Service
Recent research suggests the gut may hold the secret to boosting GLP-1 levels naturally
Demand has outstripped supply, and when a product is both effective and scarce, there is little pressure to lower prices